George W Bush
1 May 2002
Dear President
The Transatlantic Consumer Dialogue (TACD), the forum of
the major consumer organizations in the United States and
the European Union, awaits with interest the outcome of
the EU-US summit on May 2, 2002. We are also pleased to
have been invited to meet with the Presidents, as it is
important that civil society's concerns have a place at
the table. We hope that, at this summit, you will consider
several matters that are of great concern to consumers on
both sides of the Atlantic.
Genetically Modified Organisms (GMOs)
In particular, we hope that this summit will result in a
pledge by the US not to challenge the new EU labeling and
traceability policies on GMOs at the World Trade
Organization (WTO). The EU proposals must not be weakened
because consumers everywhere want such labeling and
protection.
TACD continues to urge the governments of the EU and the
US to adopt comprehensive mandatory labeling, including
labeling of derivatives, and mandatory pre-market safety
testing and approval systems for genetically modified
food. We are pleased that the EU and US were able to agree
on guidelines for safety assessment of genetically
engineered plants, and on the role of tracing in risk
assessment and management, at a recent Codex Alimentarius
meeting.
We urge the governments to seriously explore EU proposals
on establishing systems of traceability. The recent
episode with Starlink corn, a genetically modified variety
not approved for human consumption, found in many parts of
the US food supply and in some corn exports, demonstrates
how the ability to track the movement of genetically
engineered crops could be beneficial both to consumers and
retailers and processors.
Access to Medicines
We welcome the Doha Declaration on TRIPS and access to
medicine. That declaration was the product of advocacy
from developing countries concerned about their ability to
protect the public's health. The US and the EU made a
bargain with these countries in order to obtain
negotiations on some issues for which the US and EU
advocated. Now, we must make good on that bargain,
particularly in relation to the outstanding issue of WTO
rules for exports of medicines, a topic mentioned in
paragraph 6 of the Doha Declaration.
We call upon the US and EU governments to urge the WTO to
embrace a clear statement that exports of medicines will
be permitted under Article 30 of the WTO TRIPS accord.
Every country must have the right to seek practical
mechanisms to provide access to medicine for all, an
objective of paragraph 4 of the Doha Declaration on TRIPS.
The Article 30 approach would ensure that patent owners
benefit from protections (either exclusive rights or
compensation) in markets where patents have been obtained
and products are used, while allowing importing countries,
including those with small domestic markets or gaps in
domestic technological capacity, to seek the lowest cost
qualified supplier.
The US and the EU have indicated that such an exception to
the exclusive rights of a patent be limited. This can be
accomplished by allowing such Article 30 exports only when
"the importing country certified the product is needed to
address an important public health concern." This
addresses the legitimate concerns of the US and the EU
that the export exception be limited, while providing a
practical mechanism to ensure that countries in Africa and
elsewhere (including those in developed economies), can
effectively address abuses of patent rights.
We also note that if developing countries are barred from
using Article 30 of the TRIPS to authorize exports of
medicines, they will seek other alternatives, such as
simplified procedures for exports under Article 31.k of
the TRIPS, a practice that may have important consequences
outside of the medicines area.
Trade in Services
The WTO Services negotiations raise serious concerns for
consumers particularly in relation to access to essential
goods and services and consumer and environmental
protection.
To address these concerns, TACD recommends that all
documents in the WTO services negotiations be made public
in a timely fashion. Also, the right of governments to
provide and regulate basic services in the consumer
interest should be broadly asserted in a new article of
the WTO services agreement. The right of governments to
provide access to basic services must be recognized in the
agreement and the right of governments to assure the
provision of critical services - health, education,
telecommunications, water and energy utilities - should be
protected by revising the government exemption in the
agreement to make it self-defining. It has not escaped
TACD's notice that both the EU and the US are requesting
commitments in the energy sector, an issue of great
concern to consumers and environmentalists alike.
The imposition through the General Agreement on Trade in
Services (GATS) of "necessity tests" or requirements to
only implement measures that are "the least trade
restrictive" must be rejected and the GATS articles on
market access and national treatment must be amended to
clearly state that they do not apply to non-discriminatory
domestic regulations.
Finally, we urge the EU to reconsider its WTO GATS draft
requests (April 2002) that include requests for many
nations to eliminate all restrictions on the distribution
of alcohol and tobacco. This could have a significant
impact on public health around the world. It also
underscores the need for transparency and accountability
in the negotiations. We urge the US and the EU to
unilaterally pledge to make WTO GATS request/offer
documents publicly available in a timely fashion.
Yours sincerely,
Ben Wallis, TACD Coordinator
Anna Bartolini, President, CNCU (Italian National Council
of Consumers and Users)
President of the United States
The White House
1600 Pennsylvania Avenue NW
Washington DC 20500
USA
On behalf of the TACD Steering Committee
Benedicte Federspiel, International Director,
Forbrugerrċadet (Danish Consumer Council)
Jean Ann Fox, Director, Consumer Protection, Consumer
Federation of America
Rhoda Karpatkin, President Emeritus, Consumers' Union
Felix Cohen, Director, Consumentenbond (Dutch Consumers
Association)
Ed Mierzwinski, Director, Consumer Program, Public
Interest Research Group
Jim Murray, Director, BEUC (European Consumers
Organisation)
Lori Wallach, Director, Global Trade Watch, Public Citizen
Encl:
Food-05pp-00, TACD position paper on GMOs
Letter to USTR Zoellick and Commissioner Lamy re Doha
Declaration on TRIPS
Trade-11-01, TACD position on Trade in Services
Return to: CPTech Home -> Main IP Page -> IP and Healthcare -> CPTech Page on Patent Exception for Exports to Address Health Needs |